118 related articles for article (PubMed ID: 526944)
1. Phase II evaluation of vindesine in patients with advanced colorectal carcinoma.
Carroll DS; Gralla RJ; Kemeny NE
Cancer Treat Rep; 1979; 63(11-12):2097-8. PubMed ID: 526944
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
Saiers JH; Slavik M; McKinney DR
Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
[No Abstract] [Full Text] [Related]
3. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
Diaz-Rubio E; Martin-Jimenez M
Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
[No Abstract] [Full Text] [Related]
4. Phase II trial of vindesine in adenocarcinoma of the lung.
Sledge GW; Clark GM; Von Hoff DD
Cancer Treat Rep; 1984 Mar; 68(3):557-8. PubMed ID: 6704986
[No Abstract] [Full Text] [Related]
5. Phase II trial of vindesine in advanced gastric cancer.
Kenny JB; Scarffe JH; Maley WV
Cancer Treat Rep; 1983 Jan; 67(1):89-90. PubMed ID: 6311414
[No Abstract] [Full Text] [Related]
6. Phase II evaluation of anguidine (NSC-141537) for adenocarcinoma of the colon or rectum.
Diggs CH; Scoltock MJ; Wiernik PH
Cancer Clin Trials; 1978; 1(4):297-9. PubMed ID: 757146
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of hycanthone in patients with advanced colorectal carcinoma.
Schutt AJ; Dalton RJ; Kovach JS; Moertel CG; O'Connell MJ
Cancer Treat Rep; 1983 Jun; 67(6):593-4. PubMed ID: 6861166
[No Abstract] [Full Text] [Related]
8. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny NE; Gralla RJ
Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
[No Abstract] [Full Text] [Related]
9. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
O'Connell MJ; Shani A; Rubin J; Moertel CG
Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
[No Abstract] [Full Text] [Related]
10. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
[No Abstract] [Full Text] [Related]
11. Broad phase II study of vindesine.
Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
[No Abstract] [Full Text] [Related]
13. Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer.
Schutt AJ; Hahn RG; Moertel CG; O'Connell MJ; Rubin J; Creagan ET
Cancer Treat Rep; 1983 May; 67(5):505-6. PubMed ID: 6406062
[No Abstract] [Full Text] [Related]
14. Phase II study of 3-deazauridine in advanced colorectal adenocarcinoma.
Bruno S; Creaven PJ; Ledesma E; Poster D; Yoon J; Mittelman A
Am J Clin Oncol; 1982 Feb; 5(1):69-71. PubMed ID: 7081140
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
O'Connell MJ; Rubin J; Hahn RG; Kvols LK; Moertel CG
Cancer Treat Rep; 1987 Mar; 71(3):333-4. PubMed ID: 3815402
[No Abstract] [Full Text] [Related]
16. Phase II trial of mitoxantrone in advanced colorectal cancer.
Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
[No Abstract] [Full Text] [Related]
17. Phase II trial of vindesine in patients with acute leukemia.
Sklaroff RB; Arlin Z; Young CW
Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of N-methylformamide in patients with advanced colorectal cancer.
Tchekmedyian NS; Kaplan RS; Eisenberger M; Abrams J; Van Echo D
Cancer Treat Rep; 1987 May; 71(5):541-2. PubMed ID: 3567980
[No Abstract] [Full Text] [Related]
19. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
Locker GY; Lanzotti V; Sweet D; Lad T; Khandekar J; Stiff P; Johnson C; Miller S
Cancer Treat Rep; 1984 Oct; 68(10):1303-4. PubMed ID: 6525605
[No Abstract] [Full Text] [Related]
[Next] [New Search]